CS logo
small CS logo
Centrum Alergologii Teresa Hofman

Poznan, Poland
Allergist in Poznań
Bogusławskiego 16A, 60-214 Poznań

About Centrum Alergologii Teresa Hofman


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
HAL Allergy
3
Eli Lilly and Company
2
Genentech, Inc.
2
Hoffmann-La Roche
2
Artu Biologicals
1
Glenmark Pharmaceuticals Ltd. India
1
Total Rows: 6

Clinical Trials at Centrum Alergologii Teresa Hofman


During the past decade, Centrum Alergologii Teresa Hofman conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years221111000000Started TrialsCompleted Trails2019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis
2008-12-01
2011-12-01
Unknown status
374
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
2011-10-01
2013-04-01
Completed
273
SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding
2012-07-01
2013-04-01
Completed
270
SUBLIVAC FIX Phleum Pratense DT/DRF
2012-09-01
2013-05-01
Completed
266
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,081
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-08-31
2016-12-28
Completed
348
SUBLIVAC FIX Birch Phase III Short-term Efficacy
2014-09-01
2015-11-01
Completed
406
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller
2019-10-31
2022-05-19
Completed
135

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centrum Alergologii Teresa Hofman" #1 sponsor was "HAL Allergy" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Artu Biologicals" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Alergologii Teresa Hofman" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator and "Glenmark Pharmaceuticals S.A." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHAL Allergy: 3HAL Allergy: 3Eli Lilly and Company: 2Eli Lilly and Company: 2Genentech, Inc.: 2Genentech, Inc.: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Artu Biologicals: 1Artu Biologicals: 1GlenmarkPharmaceuticals Ltd.India: 1GlenmarkPharmaceuticals Ltd.India: 1

Created with Highcharts 11.1.0Top CollaboratorsDermira, Inc.: 2Dermira, Inc.: 2GlenmarkPharmaceuticals S.A.: 1GlenmarkPharmaceuticals S.A.: 1

Clinical Trials Conditions at Centrum Alergologii Teresa Hofman


According to Clinical.Site data, the most researched conditions in "Centrum Alergologii Teresa Hofman" are "Asthma" (4 trials), "Allergic Rhinoconjunctivitis" (3 trials), "Allergic Rhinitis" (2 trials), "Atopic Dermatitis" (2 trials) and "Birch Pollen Induced Rhinitis/Rhinoconjunctivitis" (1 trials). Many other conditions were trialed in "Centrum Alergologii Teresa Hofman" in a lesser frequency.

Clinical Trials Intervention Types at Centrum Alergologii Teresa Hofman


Most popular intervention types in "Centrum Alergologii Teresa Hofman" are "Drug" (8 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Lebrikizumab" (4 trials), "SUBLIVAC FIX Birch" (2 trials), "Astegolimab" (1 trials) and "MTPS9579A" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centrum Alergologii Teresa Hofman


The vast majority of trials in "Centrum Alergologii Teresa Hofman" are 11 trials for "All" genders.

Clinical Trials Status at Centrum Alergologii Teresa Hofman


Currently, there are NaN active trials in "Centrum Alergologii Teresa Hofman". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centrum Alergologii Teresa Hofman, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Alergologii Teresa Hofman, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 5Phase 2: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1Unknown status: 1Unknown status: 1